tiprankstipranks
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market
ABCL
AbCellera Biologics
RESEARCH TOOLSreports
Want to see ABCL full AI Analyst Report?

AbCellera Biologics (ABCL) Stock News & Sentiment

2,512 Followers
AbCellera Biologics Announces Oversubscribed $200 Million Offering
Premium
Company Announcements
AbCellera Biologics Announces Oversubscribed $200 Million Offering
1M ago
8K
ABCL
AbCellera Price Target Raised to $15 on Best-in-Class ABCL635 Phase 2 Data and Strategic Pipeline Momentum
Premium
Ratings
AbCellera Price Target Raised to $15 on Best-in-Class ABCL635 Phase 2 Data and Strategic Pipeline Momentum
1M ago
ABCL
AbCellera Earnings Call Balances Cash Strength With Risk
Premium
Company Announcements
AbCellera Earnings Call Balances Cash Strength With Risk
1M ago
ABCL
AbCellera to Report Phase 2 Menopause Therapy Data
Premium
Company Announcements
AbCellera to Report Phase 2 Menopause Therapy Data
1M ago
8K
ABCL
Analyst Brendan Smith Reiterates Buy on AbCellera, Citing Strong Liquidity and Upcoming Phase 2 Data for ABCL635 in Hot-Flash Market
Premium
Ratings
Analyst Brendan Smith Reiterates Buy on AbCellera, Citing Strong Liquidity and Upcoming Phase 2 Data for ABCL635 in Hot-Flash Market
1M ago
ABCL
AbCellera and Vertex launch autoimmune T-cell engager partnership
Premium
Company Announcements
AbCellera and Vertex launch autoimmune T-cell engager partnership
2M ago
8K
ABCL
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
Premium
Market News
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
2M ago
ABCL
NUVB
More ABCL News >

ABCL News on the Web

AbCellera advances new menopause antibody in clinical spotlight
TipRanks News
Bullish
Menopause Drug Breakthrough Sends AbCellera Stock Soaring
TipRanks News
Bullish
Insider Confidence Surge: Director Makes Bold Move on AbCellera Biologics
TipRanks News
Neutral
AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity
Insider Monkey
Bullish
Top Executives Quietly Double Down on AbCellera Biologics Stock
TipRanks News
Neutral
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
Insider Monkey
Neutral
AbCellera (ABCL) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
S&P 500 Holds 7,753 Below Record as Brent Hits $88.89 and the 10-Year Reaches 4.726% Before July CPI
TradingNEWS.com
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average5.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ABCL’s Media Buzz Sentiment?
Currently, no data Available
What is ABCL’s weekly average amount of articles?
In an average week, 5.25 articles about ABCL are published.
    What is ABCL’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    BAYRYBayer
    MRKMerck & Company
    TMDXTransMedics Group
    FSPKFFisher & Paykel Healthcare Corporation Limited
    KURAKura Oncology
    Showing the stocks with the most bullish news sentiment over the past week